Procyon Advisors, LLC Merck & Co., Inc. Transaction History

Procyon Advisors, LLC

$1.54 Billion
Q4 2024

A detailed history of Procyon Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Procyon Advisors, LLC holds 39,670 shares of MRK stock, worth $3.88 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

39,670

Previous 42,267 6.14%

Holding current value

$3.88 Million

Previous $4.8 Million 17.77%

% of portfolio

0.26%

Previous 0.33%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$96.31 - $114.76 $250,117 - $298,031	-2,597 Reduced 6.14%	39,670 $3.95 Million
Q3 2024 Oct 11, 2024	BUY	$111.15 - $128.97 $84,474 - $98,017	760 Added 1.83%	42,267 $4.8 Million
Q2 2024 Aug 02, 2024	BUY	$123.8 - $132.96 $210,707 - $226,297	1,702 Added 4.28%	41,507 $5.14 Million
Q1 2024 Apr 15, 2024	BUY	$113.24 - $131.95 $440,956 - $513,813	3,894 Added 10.84%	39,805 $5.25 Million
Q4 2023 Jan 18, 2024	SELL	$100.18 - $109.02 $49,889 - $54,291	-498 Reduced 1.37%	35,911 $3.92 Million
Q3 2023 Oct 10, 2023	BUY	$102.95 - $114.33 $1.57 Million - $1.74 Million	15,239 Added 71.98%	36,409 $3.75 Million
Q2 2023 Jul 17, 2023	BUY	$108.61 - $118.38 $929,049 - $1.01 Million	8,554 Added 67.8%	21,170 $2.44 Million
Q1 2023 Apr 10, 2023	SELL	$102.94 - $114.86 $319,937 - $356,984	-3,108 Reduced 19.77%	12,616 $1.34 Million
Q4 2022 Jan 19, 2023	BUY	$87.44 - $112.11 $188,957 - $242,269	2,161 Added 15.93%	15,724 $0
Q3 2022 Oct 17, 2022	SELL	$84.53 - $94.96 $85,797 - $96,384	-1,015 Reduced 6.96%	13,563 $1.17 Million
Q2 2022 Jul 11, 2022	SELL	$83.49 - $94.64 $244,959 - $277,673	-2,934 Reduced 16.75%	14,578 $1.33 Million
Q1 2022 Apr 18, 2022	BUY	$73.51 - $82.4 $83,507 - $93,606	1,136 Added 6.94%	17,512 $1.44 Million
Q4 2021 Jan 18, 2022	SELL	$72.28 - $90.54 $74,014 - $92,712	-1,024 Reduced 5.89%	16,376 $1.26 Million
Q3 2021 Oct 14, 2021	SELL	$71.68 - $78.83 $402,913 - $443,103	-5,621 Reduced 24.42%	17,400 $1.31 Million
Q2 2021 Jul 22, 2021	BUY	$70.31 - $77.77 $746,762 - $825,995	10,621 Added 85.65%	23,021 $1.79 Million
Q1 2021 Apr 29, 2021	BUY	$68.86 - $81.11 $118,990 - $140,158	1,728 Added 16.19%	12,400 $956,000
Q4 2020 Jan 19, 2021	BUY	$71.77 - $79.65 $38,181 - $42,373	532 Added 5.25%	10,672 $873,000
Q3 2020 Oct 22, 2020	SELL	$73.18 - $82.95 $3,366 - $3,815	-46 Reduced 0.45%	10,140 $841,000
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $82,884 - $94,313	1,177 Added 13.06%	10,186 $788,000
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $887 - $1,229	-14 Reduced 0.16%	9,009 $693,000
Q4 2019 Feb 21, 2020	BUY	$77.58 - $87.54 $700,004 - $789,873	9,023 New	9,023 $821,000

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.

Account

Procyon Advisors, LLC Merck & Co., Inc. Transaction History